Anaptysbio (ANAB) Research & Development (2016 - 2025)
Historic Research & Development for Anaptysbio (ANAB) over the last 10 years, with Q3 2025 value amounting to $31.4 million.
- Anaptysbio's Research & Development fell 2559.7% to $31.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $153.0 million, marking a year-over-year decrease of 114.75%. This contributed to the annual value of $163.8 million for FY2024, which is 2385.57% up from last year.
- Latest data reveals that Anaptysbio reported Research & Development of $31.4 million as of Q3 2025, which was down 2559.7% from $37.8 million recorded in Q2 2025.
- Anaptysbio's 5-year Research & Development high stood at $42.6 million for Q4 2024, and its period low was $20.8 million during Q2 2022.
- For the 5-year period, Anaptysbio's Research & Development averaged around $31.3 million, with its median value being $31.4 million (2025).
- As far as peak fluctuations go, Anaptysbio's Research & Development skyrocketed by 5794.95% in 2023, and later tumbled by 2559.7% in 2025.
- Quarter analysis of 5 years shows Anaptysbio's Research & Development stood at $26.8 million in 2021, then dropped by 12.71% to $23.4 million in 2022, then surged by 43.43% to $33.5 million in 2023, then grew by 27.04% to $42.6 million in 2024, then fell by 26.26% to $31.4 million in 2025.
- Its last three reported values are $31.4 million in Q3 2025, $37.8 million for Q2 2025, and $41.2 million during Q1 2025.